Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) has announced the successful completion of regulatory inspection from the U.S. Food and Drug Administration (FDA) for its Active Pharmaceutical Ingredient (API) facility in Chennai, India, conducted during the period July 8th - 12th, 2019. The regulatory audit resulted in zero observations.
Shares of NATCO PHARMA LTD. was last trading in BSE at Rs.528.5 as compared to the previous close of Rs. 529.65. The total number of shares traded during the day was 2581 in over 164 trades.
The stock hit an intraday high of Rs. 532 and intraday low of 527.35. The net turnover during the day was Rs. 1366031.